Opinion
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are often choosing between two bad options: restricting access or raising consumer costs.
Expanding access to new, highly effective weight-loss medications could prevent more than 40,000 deaths a year in the United ...
Not everybody loses the same amount of weight on medications such as Ozempic and Saxenda—treatment indication, dosage, and ...
TUESDAY, Oct. 15, 2024 (HealthDay News) -- Pharmacists may continue making compounded versions of the weight-loss medication ...
Unemployed people living with obesity could be given new weight loss jabs to help them get back into work, the health ...
New research shows that Ozempic and similar drugs reduce opioid overdoses by 40% and alcohol intoxication by 50% in people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback